抗发作基因疗法用于焦点皮质发育不良
Amanda Almacellas Barbanoj1, Robert T Graham1, Benito Maffei1
1Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.
Brain : a journal of neurology
|December 15, 2023
概括
使用Kv1.1通道过度表达的基因疗法在焦点皮质失生症小鼠模型中减少了64%的发作. 这种方法对皮质发育的治疗有希望,但没有改善认知或行为缺陷.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 焦点皮质失调症 (FCD) 是导致和认知问题的发育性大脑异常.
- 第二种类型的FCD与mTOR过活性有关,并且通常对手术有抗性.
- 基因疗法为FCD治疗提供了一个替代方案,特别是当手术具有风险时.
研究的目的:
- 评估Kv1.1通道基因疗法在与mTOR相关的FCD的小鼠模型中.
- 评估治疗在减少发作和改善行为缺陷方面的有效性.
主要方法:
- 通过在子宫内用RHEB等离子体进行电穿孔,创建了FCD的小鼠模型.
- 基因疗法涉及AV9将Kv1.1转基因 (AAV9-CAMK2A-EKC) 传递到失塑区域.
- 电皮质谱和行为测试量了和认知功能.
主要成果:
- AAV9-CAMK2A-EKC基因治疗显著减少了约64%的发作频率.
- 在评估前额叶功能的行为测试中,治疗没有改善或恶化表现.
- 在没有发作的小鼠中,没有观察到对间歇性放电或行为的影响.
结论:
- Kv1.1基因疗法有效地针对mTOR相关的FCD中的类表型.
- 这种基因治疗方法具有治疗FCD相关的翻译潜力.
- 认知和行为并发症可能无法通过专注于电路兴奋性的干预来解决.
更多相关视频
06:04Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
867
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
8.6K
相关概念视频
01:24Arteries of the Lower Limbs
191
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
191
00:59Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
01:13Seizures: Classification
372
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
372